Eugenia Dragunsky

909 total citations
29 papers, 721 citations indexed

About

Eugenia Dragunsky is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Genetics. According to data from OpenAlex, Eugenia Dragunsky has authored 29 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 24 papers in Infectious Diseases and 10 papers in Genetics. Recurrent topics in Eugenia Dragunsky's work include Viral Infections and Immunology Research (26 papers), Viral gastroenteritis research and epidemiology (23 papers) and Virus-based gene therapy research (10 papers). Eugenia Dragunsky is often cited by papers focused on Viral Infections and Immunology Research (26 papers), Viral gastroenteritis research and epidemiology (23 papers) and Virus-based gene therapy research (10 papers). Eugenia Dragunsky collaborates with scholars based in United States, Russia and United Kingdom. Eugenia Dragunsky's co-authors include Konstantin Chumakov, Ivanov Ap, Gennady V. Rezapkin, Inessa S. Levenbook, Diana Kouiavskaia, Majid Laassri, Rolf E. Taffs, Elena Cherkasova, Vadim I. Agol and Yuxin Ran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Eugenia Dragunsky

29 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugenia Dragunsky United States 17 434 416 196 149 117 29 721
Marion S. Freistadt United States 12 343 0.8× 259 0.6× 208 1.1× 175 1.2× 54 0.5× 18 581
So Hashizume Japan 15 227 0.5× 231 0.6× 184 0.9× 165 1.1× 54 0.5× 27 497
F. Horaud France 11 380 0.9× 274 0.7× 181 0.9× 74 0.5× 79 0.7× 33 518
Donna C. Porter United States 15 349 0.8× 329 0.8× 307 1.6× 91 0.6× 60 0.5× 25 732
Christopher T. Cornell United States 14 581 1.3× 305 0.7× 410 2.1× 269 1.8× 99 0.8× 15 950
Marina S. Kolesnikova Russia 16 702 1.6× 468 1.1× 457 2.3× 111 0.7× 184 1.6× 25 1.0k
Liisa Piirainen Finland 8 311 0.7× 183 0.4× 131 0.7× 146 1.0× 67 0.6× 14 514
Elena A. Tolskaya Russia 16 730 1.7× 484 1.2× 475 2.4× 112 0.8× 181 1.5× 28 1.1k
L.R. Boulger United Kingdom 9 263 0.6× 290 0.7× 94 0.5× 128 0.9× 64 0.5× 20 551
Thomas Hämmerle Austria 12 320 0.7× 231 0.6× 291 1.5× 87 0.6× 76 0.6× 17 627

Countries citing papers authored by Eugenia Dragunsky

Since Specialization
Citations

This map shows the geographic impact of Eugenia Dragunsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenia Dragunsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenia Dragunsky more than expected).

Fields of papers citing papers by Eugenia Dragunsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenia Dragunsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenia Dragunsky. The network helps show where Eugenia Dragunsky may publish in the future.

Co-authorship network of co-authors of Eugenia Dragunsky

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenia Dragunsky. A scholar is included among the top collaborators of Eugenia Dragunsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenia Dragunsky. Eugenia Dragunsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viktorova, Ekaterina G., Sunil K. Khattar, Diana Kouiavskaia, et al.. (2018). Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis. Journal of Virology. 92(17). 22 indexed citations
2.
Kouiavskaia, Diana, Zhaochun Chen, Eugenia Dragunsky, et al.. (2015). A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses. Journal of Clinical Virology. 65. 32–37. 9 indexed citations
3.
Ford-Siltz, Lauren A., Ekaterina G. Viktorova, Ben Zhang, et al.. (2014). New Small-Molecule Inhibitors Effectively Blocking Picornavirus Replication. Journal of Virology. 88(19). 11091–11107. 38 indexed citations
4.
Dragunsky, Eugenia, et al.. (2014). MicroRNAs as potential biomarkers for VERO cell tumorigenicity. Vaccine. 32(37). 4799–4805. 15 indexed citations
5.
Rezapkin, Gennady V., А. А. Неверов, Elena Cherkasova, et al.. (2010). Repertoire of antibodies against type 1 poliovirus in human sera. Journal of Virological Methods. 169(2). 322–331. 10 indexed citations
6.
Neznanov, Nickolay, Eugenia Dragunsky, Konstantin Chumakov, et al.. (2008). Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication. PLoS ONE. 3(4). e1887–e1887. 38 indexed citations
7.
Dragunsky, Eugenia, Ivanov Ap, Shinobu Abe, et al.. (2006). Further Development of a New Transgenic Mouse Test for the Evaluation of the Immunogenicity and Protective Properties of Inactivated Poliovirus Vaccine. The Journal of Infectious Diseases. 194(6). 804–807. 6 indexed citations
8.
Ochiai, Hidenobu, Gary E. Archer, Eugenia Dragunsky, et al.. (2006). Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.. Clinical Cancer Research. 12(4). 1349–1354. 55 indexed citations
9.
Ap, Ivanov, Eugenia Dragunsky, & Konstantin Chumakov. (2006). 1,25‐Dihydroxyvitamin D3 Enhances Systemic and Mucosal Immune Responses to Inactivated Poliovirus Vaccine in Mice. The Journal of Infectious Diseases. 193(4). 598–600. 60 indexed citations
10.
Ap, Ivanov & Eugenia Dragunsky. (2005). ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Review of Vaccines. 4(2). 167–172. 18 indexed citations
11.
Ap, Ivanov, et al.. (2005). Determination of poliovirus-specific IgA in saliva by ELISA tests. Journal of Virological Methods. 126(1-2). 45–52. 7 indexed citations
12.
Dragunsky, Eugenia, Ivanov Ap, Anna V. Ivshina, et al.. (2004). Evaluation of Immunogenicity and Protective Properties of Inactivated Poliovirus Vaccines: A New Surrogate Method for Predicting Vaccine Efficacy. The Journal of Infectious Diseases. 190(8). 1404–1412. 33 indexed citations
13.
Levenbook, Inessa S., et al.. (2000). Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993–1999. Vaccine. 19(2-3). 163–166. 6 indexed citations
14.
Rezapkin, Gennady V., et al.. (1999). Mutations in Sabin 2 Strain of Poliovirus and Stability of Attenuation Phenotype. Virology. 258(1). 152–160. 30 indexed citations
15.
Rezapkin, Gennady V., Eugenia Dragunsky, Monica Parker, et al.. (1998). Genetic Stability of Sabin 1 Strain of Poliovirus: Implications for Quality Control of Oral Poliovirus Vaccine. Virology. 245(2). 183–187. 9 indexed citations
16.
Maximova, Olga A., Eugenia Dragunsky, Rolf E. Taffs, et al.. (1996). Monkey Neurovirulence Test for Live Mumps Vaccine. Biologicals. 24(3). 223–224. 14 indexed citations
17.
18.
Rezapkin, Gennady V., et al.. (1995). Microevolution of Type 3 Sabin Strain of Poliovirus in Cell Cultures and Its Implications for Oral Poliovirus Vaccine Quality Control. Virology. 211(2). 377–384. 31 indexed citations
19.
Rezapkin, Gennady V., et al.. (1994). Microevolution of Sabin 1 Strain in Vitro and Genetic Stability of Oral Poliovirus Vaccine. Virology. 202(1). 370–378. 36 indexed citations
20.
Chumakov, Konstantin, et al.. (1994). Consistent selection of mutations in the 5′‐untranslated region of oral poliovirus vaccine upon passaging in vitro. Journal of Medical Virology. 42(1). 79–85. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion S. Freistadt Breakdown of academic impact, for papers by So Hashizume Breakdown of academic impact, for papers by F. Horaud Breakdown of academic impact, for papers by Donna C. Porter Breakdown of academic impact, for papers by Christopher T. Cornell Breakdown of academic impact, for papers by Marina S. Kolesnikova Breakdown of academic impact, for papers by Liisa Piirainen Breakdown of academic impact, for papers by Elena A. Tolskaya Breakdown of academic impact, for papers by L.R. Boulger Breakdown of academic impact, for papers by Thomas Hämmerle
Rankless by CCL
2026